In this webinar designed for patients and caregivers, Leena Gandhi, M.D., Ph.D., of NYU Langone, discusses current immunotherapy treatment options for patients with lung cancer, and the latest breakthroughs that are paving the way to for immunotherapy to help even more patients.
Dr. Gandhi is the Director of Thoracic Medical Oncology at New York University’s Langone Medical Center and an Associate Professor of Medicine at NYU’s Laura and Isaac Perlmutter Cancer Center. Throughout her career, she has focused on using immunotherapy to treat lung cancer, as well as the identification and characterization of biomarkers―such as PD-L1 expression―to help doctors better predict and monitor how patients might respond, or are responding to, immunotherapies.
Cancer Research Institute's webinar series, "Cancer Immunotherapy and You," are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This series is presented by Genentech and LabAnswer and its employees, with generous support from Abbvie, Celldex Therapeutics, NewLink Genetics, and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars